This is an economic evaluation that meets the criteria for inclusion on NHS EED.
Rheingans R, Atherly D, Anderson J. Distributional impact of rotavirus vaccination in 25 GAVI countries: estimating disparities in benefits and cost-effectiveness. Vaccine 2012; 30(Supplement 1): A15-A23
Subject indexing assigned by NLM
Cost-Benefit Analysis; Developing Countries; Diarrhea /economics /epidemiology /mortality /prevention & Humans; Immunization Programs /economics; India /epidemiology; Infant; Infant, Newborn; Rotavirus Infections /economics /epidemiology /mortality /prevention & Rotavirus Vaccines /administration & control; control; distribution; dosage /economics /supply &
Date bibliographic record published